For instance, Koskinen et al. [46] found that in osteoarthritis, plasma adiponectin levels are associated with the bone destruction grade, and adiponectin enhances the release of NO, IL-6, MMP-1 and MMP-3 from primary chondrocytes through the MAPK signaling pathway. The gene discussed is ADIPOQ; the disease is osteoarthritis.